PE Anti-Mouse IL-17A Antibody[TC11-18H10.1]

PE Anti-Mouse IL-17A Antibody[TC11-18H10.1]

Introducing the PE Anti-Mouse IL-17A Antibody [TC11-18H10.1], a highly reliable and efficient tool for immunological research. This product is specifically designed to detect and quantify the presence of Interleukin-17A (IL-17A) in mouse samples, enabling researchers to gain valuable insights into the immune response and inflammatory processes.

The PE Anti-Mouse IL-17A Antibody [TC11-18H10.1] exhibits exceptional specificity and sensitivity, ensuring accurate and reproducible results. It has been meticulously developed and rigorously validated to guarantee optimal performance in various applications, including flow cytometry and immunofluorescence.

This antibody is conjugated with Phycoerythrin (PE), a fluorescent dye known for its bright and stable signal, allowing for easy detection and visualization of IL-17A. The PE Anti-Mouse IL-17A Antibody [TC11-18H10.1] offers excellent staining intensity and minimal background noise, facilitating precise identification and quantification of IL-17A-expressing cells.

Furthermore, this product demonstrates exceptional lot-to-lot consistency, ensuring consistent and reliable results across experiments. Its high affinity and specificity for IL-17A make it an indispensable tool for researchers studying immune responses, autoimmune diseases, and inflammatory disorders in mouse models.

The PE Anti-Mouse IL-17A Antibody [TC11-18H10.1] is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and error-prone antibody conjugation procedures. It is provided in a vial with optimal storage conditions, ensuring long-term stability and preserving its functionality.

In summary, the PE Anti-Mouse IL-17A Antibody [TC11-18H10.1] is a superior reagent that offers exceptional performance, reliability, and convenience for researchers in the field of immunology. With its outstanding specificity, sensitivity, and ease of use, this antibody is an invaluable asset for advancing scientific understanding and discovering novel therapeutic targets.